tiprankstipranks
Tenaya Therapeutics (TNYA)
NASDAQ:TNYA
US Market
Holding TNYA?
Track your performance easily

Tenaya Therapeutics (TNYA) Financial Statements

1,581 Followers

Tenaya Therapeutics Financial Overview

Tenaya Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.477; its P/E ratio is -2.42; Tenaya Therapeutics is scheduled to report earnings on March 25, 2025, and the estimated EPS forecast is $-0.31. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -25.63M$ -29.43M$ -32.23M$ -31.45M$ -30.92M
EBITDA$ -22.52M$ -26.34M$ -29.34M$ -29.27M$ -28.74M
Net Income Common Stockholders$ -25.63M$ -29.43M$ -32.20M$ -29.97M$ -29.14M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 79.47M$ 99.30M$ 122.25M$ 104.64M$ 121.75M
Total Assets$ 140.58M$ 163.19M$ 184.90M$ 170.51M$ 193.40M
Total Debt$ 14.54M$ 15.57M$ 11.37M$ 12.42M$ 12.04M
Net Debt$ -64.93M$ -83.73M$ -110.88M$ -92.22M$ -109.71M
Total Liabilities$ 27.98M$ 29.19M$ 26.72M$ 31.09M$ 28.51M
Stockholders Equity$ 112.60M$ 134.04M$ 158.18M$ 139.42M$ 164.88M
Cash Flow-
Free Cash Flow$ -20.02M$ -23.69M$ -29.22M$ -22.32M$ -23.65M
Operating Cash Flow$ -19.84M$ -23.62M$ -28.66M$ -21.92M$ -23.64M
Investing Cash Flow$ -30.10M$ 21.61M$ -4.49M$ -14.92M$ 30.49M
Financing Cash Flow$ 31.00K$ 570.00K$ 46.77M$ 371.00K-
Currency in USD

Tenaya Therapeutics Earnings and Revenue History

Tenaya Therapeutics Debt to Assets

Tenaya Therapeutics Cash Flow

Tenaya Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis